These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3280478)

  • 1. Effector lymphocyte response to homologous tumor antigens in various stages of malignant disease as monitored by leukocyte adherence inhibition--cell mediated immunity (LAI-CMI).
    Tsang PH; Roboz JP; Holland JF; Bekesi JG
    Immunol Lett; 1988 Jan; 17(1):63-70. PubMed ID: 3280478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A computerized tube leukocyte adherence inhibition assay to detect antitumor immunity in early human cancer: a review of two years' experience.
    Ayeni RO; Tataryn DN; MacFarlane JK; Thomson DM; Schwartz R
    Surgery; 1980 Apr; 87(4):380-9. PubMed ID: 6989000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition.
    Flores M; Marti JH; Grosser N; MacFarlane JK; Thomson DM
    Cancer; 1977 Feb; 39(2):494-505. PubMed ID: 319891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioisotopic 51Cr-leukocyte adherence inhibition (LAI) assay. I. Demonstration of anti-tumor immunity in patients with breast carcinoma.
    Tsang PH; Tangnavarad K; Lesnick G; Perloff M; Holland JF; Bekesi JG
    J Immunol Methods; 1980; 36(2):119-35. PubMed ID: 7000908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organ specific neoantigens reactive in the leukocyte adherence inhibition assay: affinity purification of human colon carcinoma antigen and its cross-reactive protein using monoclonal antibodies.
    Hadas E; Fink A; Gembom E; Harpaz N; Shani A; Bentwich Z; Eshhar Z
    Cancer Res; 1986 Oct; 46(10):5201-5. PubMed ID: 2428475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial purification of organ-specific neoantigens from human colon and breast cancer by affinity chromatography with human tumour-specific gamma-globulin.
    Thomson DM; Tataryn DN; Schwartz R
    Br J Cancer; 1980 Jan; 41(1):86-99. PubMed ID: 7362781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses in lung cancer patients measured by a modified leukocyte adherence inhibition test using serum.
    Sanner T; Kotlar HK; Eker P
    Cancer Lett; 1980 Feb; 8(4):283-90. PubMed ID: 6989487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An isolated enriched organ-specific cancer neoantigen of human lung cancer for leukocyte adherence inhibition assays.
    Dubois AE; Thomson DM; Sutherland ME; Scanzano R
    Cancer Res; 1985 Jun; 45(6):2661-9. PubMed ID: 3886136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of serum blocking factors on leucocyte adherence inhibition and PHA lymphocyte blastogenesis in breast cancer patients.
    Fujisawa T; Yonemoto RH; Waldman SR
    Jpn J Surg; 1981; 11(6):406-12. PubMed ID: 6799680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a Mr 40,000 polypeptide from colorectal cancer which expresses organ-specific cancer neoantigen activity as determined by leukocyte adherence inhibition.
    Artigas C; Thomson DM; Durko M; Sutherland M; Scanzano R; Shenouda G; Dubois AE
    Cancer Res; 1986 Apr; 46(4 Pt 1):1874-81. PubMed ID: 2418955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
    Tsang PH; Holland JF; Bekesi JG
    J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-populations involved in the humoral leukocyte adherence inhibition reaction. The T8-suppressor/cytotoxic cells are both effectors and responders.
    Moskaug JO; Kotlar HK; Sanner T
    Eur J Cancer Clin Oncol; 1987 Feb; 23(2):149-56. PubMed ID: 2965016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking of the response by human T-lymphocytes to extracts of autologous cancer by monoclonal antibody to Class-I major histocompatibility complex gene products in the leukocyte adherence inhibition assay.
    Shenouda G; Thomson DM
    Cancer Res; 1984 Jul; 44(7):2762-8. PubMed ID: 6609766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte adherence inhibition by soluble tumor antigens in breast cancer patients.
    Fujisawa T; Waldman SR; Yonemoto RH
    Cancer; 1977 Feb; 39(2):506-13. PubMed ID: 65207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumor immunity in breast cancer evaluated by a computerized tube leukocyte adherence inhibition (LAI) assay.
    Fink A; Shani A; Feldman B; Wechsler U; Pfeffermann R; Eliraz A; Offer S; Harpaz N; Bentwich Z
    Eur J Surg Oncol; 1989 Feb; 15(1):17-9. PubMed ID: 2645173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of leukocyte adherence in women with breast cancer using a variety of tissue extracts.
    Fritze D; Kaufmann M; Drings P; Fedra G
    Oncology; 1978; 35(6):242-5. PubMed ID: 370704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tube leukocyte adherence inhibition (LAI) assay in gastrointestinal (GIT) cancer.
    Tataryn DN; MacFarlane JK; Murray D; Thomson DM
    Cancer; 1979 Mar; 43(3):898-912. PubMed ID: 371789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
    Halliday WJ; Koppi TA; Khan JM; Davis NC
    J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression by human fetal organs of organ-specific cancer neoantigens as measured by leukocyte adherence inhibition.
    Gubersky M; Thomson DM; Lajzerowicz M
    Cancer Immunol Immunother; 1986; 21(2):107-13. PubMed ID: 3633212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of different states of immunity to colon cancer in rats by a leukocyte adherence inhibition (LAI) assay assessing the adherence of T lymphocytes and monocytes selectively.
    Morizane T; Sjögren HO
    Int J Cancer; 1983 Jun; 31(6):813-6. PubMed ID: 6345409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.